Jun Guo
20PUBLICATIONS
7CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (20)
Sort by Publication Date:
|Mar 27, 2026
A Biomimetic Self-Adjuvanting Glycoprotein Vaccine Platform Elicits Potent Antitumor Immunity against GD2-Positive Cancers.Dong Ding, Chang Cao, Yu Wen
|Feb 27, 2026
Highly Potent Th1-Type NKT Cell Agonists as Immunotherapeutic Agents via Conformational Restriction Design.Yu Wen, Ye-Hui Wu, Qian-Nan Sun
|Jul 18, 2025
Significantly Boosted Th2-Selective Activity of NKT Cell Agonist Enabled by Sulfonamide Hydrogen-Bond Design.Yu Wen, En-Yang Wang, Ye-Hui Wu
|Dec 19, 2024
Diphtheria Toxoid-Derived T-Helper Epitope and α-galactosylceramide Synergistically Enhance the Immunogenicity of Glycopeptide Antigen.Jing-Jing Du, Shi-Hao Zhou, Jin Liu
|Jul 20, 2024
Rationally Designed Highly Potent NKT Cell Agonists with Different Cytokine Selectivity through Hydrogen-Bond Interaction.Yu Wen, Dong Ding, Meng-Qiang Luo
|Apr 08, 2024
Multifunctional Lipidated Protein Carrier with a Built-In Adjuvant as a Universal Vaccine Platform Potently Elevates Immunogenicity of Weak Antigens.Shi-Hao Zhou, Ru-Yan Zhang, Yu Wen
Pageof 4
